Breakthrough Therapy Pathway A Success for CDER in 2013

Washington Drug Letter
A A
The FDA’s new breakthrough therapy designation has exploded in popularity, the agency says. As of Nov. 22, 108 requests for breakthrough designation have been submitted.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00